adenosine vs ethacrynic acid
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of adenosine and ethacrynic acid. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Adenocard
Edecrin
Adenosine (Adenocard) is a medicine used to treat certain types of irregular heartbeats. It belongs to a class of drugs called antiarrhythmics.
Ethacrynic acid (Edecrin) is a strong diuretic, also known as a water pill. It helps your body get rid of extra fluid.
Adenosine is used to treat a very fast heart rate in the upper chambers of your heart. This condition is called supraventricular tachycardia (SVT). Adenosine helps to slow down your heart rate to a normal rhythm.
This medicine treats swelling (edema) caused by heart failure, liver problems like cirrhosis, and kidney disease. It can also manage fluid buildup in the belly (ascites) from cancer, unexplained swelling, and swelling due to problems with the lymph system. Edecrin can also be used short-term for hospitalized children (excluding infants) with heart problems or kidney problems.
Adenosine works by slowing down the electrical signals in your heart. This helps to interrupt the fast heart rhythm and restore a normal heartbeat. It does this by acting on specific receptors in the heart tissue.
Ethacrynic acid helps your kidneys remove extra salt and water from your body. It works in a specific part of the kidney called the loop of Henle. This reduces fluid buildup and lowers blood pressure.
No common side effects listed.
- • Loss of appetite
- • Feeling unwell
- • Stomach discomfort or pain
- • Difficulty swallowing
- • Nausea
- Supraventricular Tachycardia 94
- Hypotension 86
- Cardiac Arrest 78
- Dyspnoea 74
- Pain 67
- Drug Reaction With Eosinophilia And Systemic Symptoms 59
- Nausea 43
- Dyspnoea 42
- Acute Kidney Injury 33
- Fatigue 32
Since this medication is administered by a healthcare provider in a monitored setting, there are no specific at-home warnings.
You should not take this medicine if you cannot urinate. If you develop increasing electrolyte imbalance, increased nitrogen in your blood, and/or decreased urination during treatment for severe, worsening kidney disease, stop taking this medicine. If you experience severe, watery diarrhea, stop taking Edecrin and do not take it again. Edecrin can sometimes cause deafness, ringing in the ears, and dizziness.
It is not known if adenosine can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if adenosine passes into breast milk, so discuss this with your doctor if you are breastfeeding.
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is not known if Edecrin will harm your unborn baby. Talk to your doctor about the risks and benefits of taking this medicine during pregnancy or while breastfeeding.
Also Compare, Nearby Drugs
Compare ethacrynic acid with
How to Read This adenosine vs ethacrynic acid Comparison
adenosine is classified in the Endogenous Nucleoside (Antiarrhythmic) drug class, while ethacrynic acid sits within the Loop Diuretic class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adenosine has 399 submissions while ethacrynic acid has 209. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adenosine or ethacrynic acid.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.